Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Monday, June 29

I e P STE SESO S rc B112-27

12142 Markedly declining incidence of AIDS In persons treated
with antiretroviral therapy from 1994-1996
Robert Hogg*; Peter Phillips; D. Forrest; V. Montessori;. Raboud;
M.T. Schechter;.S.G. Montaner, Canada
12143 Outcome and cause of death in a cohort of HIV-1 infected adults in
Uganda
Neil French*; E. Lugadda; C Watera; J. Nakiyingi; E.N. Janoff;
C.F Gilks, Uganda
12144 Clinical and immunologic spectrum of disease among 2261 HIV-1 -infected patients at a hospital in Bangkok
Pauli Amornkul*; S. Tansuphasawadikul; K. Limpakarnjanarat;
J. Kaewkungwal; S. Likanonsakul; B. Eampokalap; T Naiwatanakul,
USA
12145 Activity of soft gelatin capsule formulation of saquinavir in combination
with two nucleosides in treatment-naive HIV-1 -seropositive persons
Melanie Thompson, USA
12146 Clinical manifestations of advanced HIV disease using
hospital surveillance, clinical and autopsy data in Abidjan, Cote d'lvoire
Alan E. Greenberg*; A. Kadio; A.D. Grant; S.B. Lucas; G. Djomand;
S. Kassim; A. Yapi; M. Honde; 0. Tossou; S.Z Wiktor; K.M. de Cock,
Cdted'lvoire, USA
12147 Immune activation in HIV-infected African individuals. Immunologic,
phenotypic and virologic analyses
Silvia Declich*; Guiliano Rizzardini; M. Lukwiya; M. Fabiani;
R Ferrante; C. Ble;M. Clerici, Italy
12148 Implication of a modified case definition for AIDS
Ka Hing Wong*; T.M.Y. Choi; S.S. Lee, Hong Kong (China)
12149 Clinical patterns of HIV-infection/AIDS in Ukraine
Alla D. Vovk*; S.N. Antonyak; N.P. Tchentsova; E.V. Maximenok;
A.M. Shcherbinskaya, Ukraine
12150 Clinical review of the patients with advanced HIV disease in Bulgaria
Irina Valkova*; I. Dikov; K. Kostov; T. Duhovnikova; P. Ratchev;
I. Radeva; D. Stefanova, Bulgaria
12151 Control of maternal HIV-1 disease during pregnancy
Karen Beckerman*; M. Benson; S. Dahud; M. Shannon, USA
12152 Combination therapy with nevirapine, zidovudine and a second
nucleoside analog during pregnancy
Francoise Kramer*; A. Stek; J. Homans; M. Khoury; A. Kovacs, USA
12153 Influence of maternal HIV-1 and HIV-2 on child survival in The Gambia
Martin Ota*; D. O'Donovan; L.K. Yamuah; E. Harding; K. Ariyoshi;
P. Milligan; H.C. Whittle, The Gambia
12154 Viral load studies in untreated infants from Africa
Robert]. Biggar*; M. Janes; E.T. Taha; F. Yellin; R. Broadhead;
N. Kumwenda; S. Cassol, USA, Canada, Malawi
12155 Reduction of maternal-infant transmission of Human
Immunodeficiency Virus type 1 with zidovudine (ZDV) treatment
Nilo Alfonso Galvdao*; Carmen Lucia Silva; P.S. V. Naud; E.B.M. Chaves;
S.A. Zachia; M. Larangeira; F. Dubina; F.M.L. Hartman, Brazil
12156 The potential role of intrapartum and neonatal zidovudine treatment in
reduction of perinatal HIV-1 transmission

Pilmolrat Thaithumyanon*; U. Thisyakorn; S. Limpongsanulak;
S. Punnahitananda; K. Ruxrungtham; S. Ubolyam; P. Virutamasen,
Thailand

12157 Use of zidovudine to reduce the risk of perinatal transmission of HIVinfection in the Washington Metropolitan Area
Tamara A. Rakusan*; V. Temple; L. Hart; B. Loechelt; S. Rana;
M. Young; J. Bertolli, USA
12158 Improved outcome of patients with CMV retinitis after adoption
of 1996 IAS-USA Recommendations
Pedro Cahn*; Hector Perez; C. Ochoa; M. Vazquez; S. Puente;
M. Callegar; R. Glancszpigel; C. Zala, Argentina
12159 Congenital HIV and chagas disease: Case report
Omar Atilio Marin*; Maria Beatriz; E. Bogdanowicz; G. Reboredo,
Argentina
12160 Mortality and neoplasm of HIV-1 infected children. Long-term follow-up
of pediatric AIDS clinical trials group (PACTG) participants (PACTG 219)
James Oleske*; M. T. Brady; S. Lee; M.G. Fowler; B. Cunningham;
M. Culnane; L.M. Mofenson, USA
12161 Prevalence of congenital CMV in children born to HIV-infected women
Jesus Saavedra Lozano*;J.T. Ramos Amador; A. Bodas; V. RodriguezCerrato; J. Ruiz-Contreras; J. Otero, Spain
12162 Role ofCCR5 chemokine receptor gene in vertical HIV-1 transmission
and disease progression
Nicola Principi* Susanna Esposito; C. Colasante; G. V. Zuccotti;
G. Ferraris; M. Clerici; L. Galli; M. Galli, Italy
12163 Morbidity and mortality among HIV-1 infected and uninfected
Kenyan children
Joanne Embree*; S. Njenga; P. Datta; P. Nyange; J.O. Ndinya-Achola;
FA. Plummer, Canada
12164 HIV viral load in children with lymphocytic interstitial pneumonitis
F. Bell*; M. Richardson; H. Lyall; D. Gibb; V. Novelli; S. Walters;
G. Tudor-Williams; M. Sharland, UK
12165 Fever of unknown origin in HIV-infected children
Jesus Ruiz-Contreras*; M.I. De Jose; L. Ciria; MJ. Mellado; J.T. Ramos;
J. Clemente; V. Rodriguez-Cerrato, Spain
12166 The impact of HIV-infection on in-hospital paediatric mortality at
Chris Hani Baragwanath Hospital (CHBH), South Africa
Karen Zwi*; Tammy Meyers; J.M. Pettifor; R.N. Soderlund; J.S. Galpin,
South Africa
12167 Relationship between dental eruption delay and the immunological
deficit in HIV carrier infants
Maria Regina Baptista*; TM.I. Nishimoto; A.S.P Gibbons; CS. Nucci, Brazil
12168 Vertical transmission of hepatitis C in children born to HIV-infected
mothers
Esther Ruiz-Chercoles*;J.T. Ramos; J. Ruiz-Contreras; C. Alvarez;
M.. Domingo; A. Fuertes; V. Rodriguez-Cerrato, Spain
12169 How often can signs, symptoms and immunological abnormalities
predict perinatal HIV-infection in Brazilian infants?
Marisa M. Mussi-Pinhata*; M.C. Cervi; M.L. Isaac; O.A.L. Cintra, Brazil
12170 Pertussis immunization does not affect HIV-1 progression in
perinatally infected children
Pier-Angelo Tovo*; C. Gabiano; M. De Martino; L. Galli, Italy
12171 Heart, lung, and immune abnormalities and high viral burden in rapid

pediatric HIV-1 disease
William T. Shearer*; P2C2 HIV Study Group, USA

28

12th World AIDS Conference Geneva